Shuttle Pharmaceuticals Financials
| SHPH Stock | USD 0.79 0.04 5.33% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.07 | 4.83 |
|
|
The essential information of the day-to-day investment outlook for Shuttle Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Shuttle Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Shuttle Pharmaceuticals.
Net Income |
|
Shuttle | Select Account or Indicator |
Shuttle Pharmaceuticals Stock Summary
Shuttle Pharmaceuticals competes with Lifecore Biomedical, Tilray, Organogenesis Holdings, Journey Medical, and Akanda Corp. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. The company was founded in 2012 and is based in Rockville, Maryland. Shuttle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 825693203 825693302 |
| Location | Maryland; U.S.A |
| Business Address | 401 Professional Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.shuttlepharma.com |
| Phone | (240) 403 4212 |
| Currency | USD - US Dollar |
Shuttle Pharmaceuticals Key Financial Ratios
| Return On Equity | -1.86 | ||||
| EBITDA | (3.99 M) | ||||
| Net Income | (6.59 M) | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 0.03 X |
Shuttle Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shuttle Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Shuttle Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shuttle Pharmaceuticals competition to find correlations between indicators driving Shuttle Pharmaceuticals's intrinsic value. More Info.Shuttle Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Shuttle Pharmaceuticals' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shuttle Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Shuttle Pharmaceuticals Systematic Risk
Shuttle Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shuttle Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Shuttle Pharmaceuticals correlated with the market. If Beta is less than 0 Shuttle Pharmaceuticals generally moves in the opposite direction as compared to the market. If Shuttle Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shuttle Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shuttle Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Shuttle Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Shuttle Pharmaceuticals Financials
What exactly are Shuttle Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Shuttle Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Shuttle Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Shuttle Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Shuttle Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Shuttle Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in Shuttle Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Shuttle Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Shuttle Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Shuttle Pharmaceuticals January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shuttle Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shuttle Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shuttle Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Shuttle Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shuttle Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 50.96 | |||
| Value At Risk | (8.24) | |||
| Potential Upside | 11.48 |
Complementary Tools for Shuttle Stock analysis
When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |